- Clinical Trials
- April 2024
- 40 Pages
Global
From €1208EUR$1,250USD£1,038GBP
- Clinical Trials
- October 2020
- 65 Pages
Global
From €1450EUR$1,500USD£1,246GBP
Librium is a brand name for the drug chlordiazepoxide, a benzodiazepine used to treat anxiety, panic attacks, and alcohol withdrawal. It is also used to treat symptoms of agitation, irritability, and restlessness associated with certain mental disorders. Librium is a central nervous system depressant that works by increasing the activity of gamma-aminobutyric acid (GABA), a neurotransmitter that helps regulate nerve activity in the brain.
Librium is available in tablet, capsule, and liquid forms. It is usually taken one to four times a day, depending on the condition being treated. Common side effects of Librium include drowsiness, dizziness, and confusion. More serious side effects may include difficulty breathing, changes in vision, and changes in behavior.
The Librium market is a subset of the larger mental disorders drugs market. It is a competitive market, with many different companies offering their own versions of the drug. Companies in the Librium market include Pfizer, Mylan, and Teva Pharmaceuticals. Show Less Read more